CSI Market
Sign In | Register

Sanomedics (SIMH) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access SIMH Annual Cash Flow →
Changes in quarterly cash flow trends offer perspective on how Sanomedics funds operations, investments, and shareholder returns.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Sep 30 2015)
9 Months 		(Jun 30 2015) (Mar 31 2015) (Dec 31 2014) (Sep 30 2014)
Operating Activities
Income-7.22
Depreciation & amortization0.01
Amortization of Other Assets0.83
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Disposal Group, Not Discontinued Operation, Loss (Gain) on Write-down0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation0.00
Income (Loss) from Equity Method Investments0.00
Gains (Losses) on Extinguishment of Debt0.69
Stock Compensation0.02
Debt Instrument Convertible Interest Expense-
Unrealized Gainon Fair Value Of Derivative Liabilities0.96
Income Loss On Rescission-
Prepaid Expenses And Deposits-
Sales Discounts Returns And Allowances Goods-0.01
Change In Unrealized Gain Loss On Fair Value Hedging Instruments-
Extinguishment Of Debt Gain Loss Income Tax-
Loss On Writedown Of Disposed Patents-
Loss On Rescission-
Interest Expense Deposits-
Discontinued Operation Provision For Loss Gain On Disposal Net Of Tax-0.11
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable0.24
Accounts Payable0.14
Accrued Expense0.02
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.01
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities4.30
Discontinued operations0.00
Net Cash flow from Operating Activities-0.11
Investing Activities
Capital Expenditures-0.01
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Expenditures On Patents-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments for Previous Acquisition0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Payments for Advance to Affiliate0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.01
Financing Activities
Short-term debt Net0.15
Other borrowing transactions0.00
Long-term debt - borrowings0.18
Long-term debt - repayments-0.05
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Issuance Of Stock Subscriptions Payable-
Sale Of Common Stock-
Proceeds From Revolving Line Of Credit Net-
Payments Of Convertible Notes Payable-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.28
Effect of exchange rate on cash flow0.00
Discontinued operations-0.11
Free Cash Flow-0.12
Total Cash Flow-0.19
4 historic quarters locked

Sign in to unlock the full Sanomedics cash flow history.

Sign In Create Free Account

About SIMH Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.